Huguet F
Unité INSERM 316, Faculté de Médecine, Tours, France.
Arch Int Pharmacodyn Ther. 1990 May-Jun;305:5-13.
The influence of repeated treatment with desipramine or AR-C239 on cerebral cortex alpha 1-adrenoceptors of mature (4 months), senescent (24 months) Wistar-Kyoto and mature spontaneously hypertensive rats was measured using [3H] prazosin as a ligand. Chronic desipramine treatment had no effect on [3H] prazosin binding in mature and aged Wistar-Kyoto rats but significantly decreased it in spontaneously hypertensive rats. Repeated AR-C239 treatment did not alter [3H] prazosin binding in senescent Wistar-Kyoto and mature spontaneously hypertensive rats, but significantly increased the [3H] prazosin binding density in mature Wistar-Kyoto rats. Thus, cortical alpha 1-adrenoceptors are not up-regulated by a decreased noradrenergic activity in aged or hypertensive rats as is the case in mature normotensive rats. In addition, these receptors are down-regulated by an increased noradrenergic activity in hypertensive rats only. These results suggest that the synthesis of alpha 1-adrenoceptors is impaired with age or with genetic hypertension and their degeneration is exacerbated with genetic hypertension in response to a changing environment.
使用[3H]哌唑嗪作为配体,测定了用去甲丙咪嗪或AR - C239重复治疗对成熟(4个月)、衰老(24个月)的Wistar - Kyoto大鼠以及成熟的自发性高血压大鼠大脑皮质α1 - 肾上腺素能受体的影响。慢性去甲丙咪嗪治疗对成熟和老龄Wistar - Kyoto大鼠的[3H]哌唑嗪结合无影响,但在自发性高血压大鼠中显著降低了其结合。重复AR - C239治疗未改变衰老的Wistar - Kyoto大鼠和成熟的自发性高血压大鼠的[3H]哌唑嗪结合,但显著增加了成熟Wistar - Kyoto大鼠的[3H]哌唑嗪结合密度。因此,在老龄或高血压大鼠中,皮质α1 - 肾上腺素能受体不会像在成熟正常血压大鼠中那样因去甲肾上腺素能活性降低而上调。此外,这些受体仅在高血压大鼠中因去甲肾上腺素能活性增加而下调。这些结果表明,α1 - 肾上腺素能受体的合成随年龄增长或遗传性高血压而受损,并且在不断变化的环境中,其退化在遗传性高血压中会加剧。